# US 2014/0193903 A1 · Microcarriers for Stem Cell Culture

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0193903 A1
- Document ID: US20140193903A1
- Status: Published application
- Kind: A1
- Application number: 14/134,275
- Filed: 2013-12-19
- Published: 2014-07-10
- Earliest claimed: 2008-03-17
- Assignees: Agency for Science, Technology and Research
- Applicants: Agency for Science, Technology and Research
- Inventors: Steve Oh; Marti Lecina; Andre Choo; Shaul Reuveny; Robert Zweigert; Allen Chen
- Web page: https://patentgrep.com/patent/US20140193903A1

## CPC

- C12N 5/0606: {Pluripotent embryonic cells, e.g. embryonic stem cells [ES] (embryonic germ cells C12N5/0611, induced pluripotent stem cells C12N5/0696)}
- C12N 5/0062: {General methods for three-dimensional culture}
- C12N 5/0075: {using microcarriers}
- C12N 5/0647: {Haematopoietic stem cells; Uncommitted or multipotent progenitors}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

We disclose a particle comprising a matrix coated thereon and having a positive charge, the particle being of a size to allow aggregation of primate or human stem cells attached thereto. The particle may comprise a substantially elongate, cylindrical or rod shaped particle having a longest dimension of between 50 μm and 400 μm, such as about 200 μm. It may have a cross sectional dimension of between 20 μm and 30 μm. The particle may comprise a substantially compact or spherical shaped particle having a size of between about 20 μm and about 120 μm, for example about 65 μm. We also disclose a method of propagating primate or human stem cells, the method comprising: providing first and second primate or human stem cells attached to first and second respective particles, allowing the first primate or human stem cell to contact the second primate or human stem cell to form an aggregate of cells and culturing the aggregate to propagate the primate or human stem cells for at least one passage. A method of propagating human embryonic stem cells (hESCs) in long term suspension culture using microcarriers coated in Matrigel or hyaluronic acid is also disclosed. We also disclose a method for differentiating stem cells.

## Claims

### Claim 1

A method for achieving stable, long-term culture and expansion of human pluripotent stem cells or human multipotent stem cells in suspension culture in vitro, the method comprising:
(i) attaching human pluripotent stem cells or human multipotent stem cells to a plurality of microcarriers to form microcarrier-stem cell complexes, wherein the surface of the microcarriers is coated in a matrix comprising an extracellular matrix component;
(ii) culturing the microcarrier-stem cell complexes in suspension culture;
(iii) passaging the cultured cells from (ii); and
(iv) repeating steps (i)-(iii) through at least 7 passages,
wherein stem cells in the culture after step (iv) are respectively pluripotent or multipotent, thus achieving stable, long-term culture and expansion of human pluripotent stem cells or human multipotent stem cells in suspension culture in vitro.

### Claim at position 2

2-6. (canceled)

### Claim 7 (depends on 1)

The method of claim 1 wherein the matrix comprises one or more of hyaluronic acid, laminin, fibronectin, vitronectin, collagen, elastin, heparan sulphate, dextran, dextran sulphate, chondroitin sulphate, or a mixture of laminin, collagen I, heparan sulfate proteoglycans, and entactin 1.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The method of claim 1 wherein the microcarrier comprises or consists of one or more of cellulose, dextran, hydroxylated methacrylate, collagen, gelatin, polystyrene, plastic, glass, ceramic, silicone.

### Claim 10

(canceled)

### Claim 11 (depends on 1)

The method of claim 1 wherein the microcarrier is coupled with protamine or polylysine.

### Claim 12 (depends on 1)

The method of claim 1 wherein the microcarrier is positively charged.

### Claim 13

(canceled)

### Claim 14 (depends on 1)

The method of claim 1 wherein the microcarrier is hydrophilic.

### Claim at position 11

15-16. (canceled)

### Claim 17 (depends on 1)

The method of claim 1 wherein in each repeat cycle the stem cells of step (i) are obtained from the passaged cells of step (iii) of the preceding repeat cycle.

### Claim 18 (depends on 1)

The method of claim 1 wherein in step (iv), steps (i)-(iii) are repeated through one of: at least 8 passages, at least 9 passages, at least 10 passages, at least 11 passages, at least 12 passages, at least 13 passages, at least 14 passages, at least 15 passages, at least 16 passages, at least 17 passages, at least 18 passages, at least 19 passages, at least 20 passages, at least 21 passages, at least 22 passages, at least 23 passages, at least 24 passages, at least 25 passages, at least 30 passages, at least 40 passages, at least 50 passages, at least 60 passages, at least 70 passages, at least 80 passages, at least 90 passages, at least 100 passages.

### Claim at position 14

19-21. (canceled)

### Claim 22 (depends on 1)

The method of claim 1 wherein after step (iv) at least 60% of the stem cells in the culture are respectively pluripotent or multipotent.

### Claim 23 (depends on 1)

The method of claim 1 wherein after step (iv) at least 60% of the pluripotent stem cells in the culture express one, two, three or all of Oct4, SSEA4, TRA-1-60 and Mab84.

### Claim at position 17

24-27. (canceled)

### Claim 28 (depends on 1)

The method of claim 1 further comprising the step of inducing differentiation of the stem cells obtained after step (iv).

### Claim 29 (depends on 1)

The method of claim 1 further comprising the step of inducing differentiation of the stem cells obtained after step (iv), wherein the method comprises placing the microcarrier-stem cell complexes under conditions which induce the differentiation of the stem cells.

### Claim 30 (depends on 1)

The method claim 1 wherein after step (iv) the method comprises the step of separating stem cells from the microcarriers and culturing the separated stem cells in non-microcarrier culture under conditions which induce differentiation of the stem cells.

### Claim 31 (depends on 1)

The method of claim 1 further comprising the differentiation of pluripotent stem cells, comprising:
(v) attaching pluripotent or multipotent stem cells obtained after step (iv) to a plurality of second microcarriers to form microcarrier-stem cell complexes, wherein the surface of the second microcarriers is coated in a matrix or is uncoated; and
(vi) culturing the microcarrier-stem cell complexes from (v) in suspension culture under conditions that induce the differentiation of the stem cells.

### Claim at position 22

32-35. (canceled)

### Claim 36 (depends on 31)

The method of claim 31 wherein the method further comprises:
(vii) attaching differentiated stem cells obtained from step (vi) to a plurality of third microcarriers to form microcarrier-stem cell complexes, wherein the surface of the third microcarriers is coated in a matrix or is uncoated; and
(viii) culturing the microcarrier-stem cell complexes from (vii) in suspension culture under conditions that induce the further differentiation of the differentiated stem cells.

### Claim at position 24

37-57. (canceled)

### Claim 58

A method of differentiating stem cells in vitro, comprising attaching human pluripotent stem cells or human multipotent stem cells to a plurality of microcarriers to form microcarrier-stem cell complexes, wherein the surface of the microcarriers is coated in a matrix comprising an extracellular matrix component, and culturing the microcarrier-stem cell complexes in suspension culture under conditions that induce the differentiation of the stem cells.

### Claim at position 26

59-62. (canceled)

### Claim 63 (depends on 58)

The method of claim 58 wherein the matrix comprises one or more of laminin, fibronectin, vitronectin, hyaluronic acid, collagen, elastin, heparan sulphate, dextran, dextran sulphate, chondroitin sulphate, or a mixture of laminin, collagen I, heparan sulfate proteoglycans, and entactin 1.

### Claim at position 28

64-110. (canceled)

### Claim 111

An aggregate comprising two or more microcarriers having human pluripotent or human multipotent cells attached thereto, wherein each microcarrier is suitable for use in the growth and/or differentiation of human pluripotent or human multipotent cells in in vitro suspension culture, wherein the microcarrier comprises one or more of cellulose, dextran, hydroxylated methacrylate, or collagen, wherein the surface of the microcarrier is coated in a matrix, and wherein one or a plurality of human pluripotent or human multipotent cells are attached to the matrix coating.

### Claim at position 30

112-115. (canceled)

### Claim 116 (depends on 1)

The method of claim 1, wherein the method further comprises differentiating the human pluripotent stem cells or human multipotent stem cells in culture after step (iv), comprising:
(v) attaching pluripotent or multipotent stem cells obtained after step (iv) to a plurality of second microcarriers to form microcarrier-stem cell complexes, wherein the surface of the second microcarriers is coated in a matrix or is uncoated; and
(vi) culturing the microcarrier-stem cell complexes from (v) in suspension culture under conditions that induce the differentiation of the stem cells.

### Claim 117 (depends on 116)

The method of claim 116, wherein the method further comprises:
(vii) attaching differentiated stem cells obtained from step (vi) to a plurality of third microcarriers to form microcarrier-stem cell complexes, wherein the surface of the third microcarriers is coated in a matrix or is uncoated; and
(viii) culturing the microcarrier-stem cell complexes from (vii) in suspension culture under conditions that induce the further differentiation of the differentiated stem cells.